Dolphin Medical Services Ltd

Mon 5/10/2026,16:1:0 | BSE : DOLPHMED

₹6.820.21 (3.18%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 6.94

Previous Close

₹ 6.61

Volume

29493

Mkt Cap ( ₹ Cr)

₹ 10.30

High

₹ 6.94

Low

₹ 6.31

52 Week High

₹ 9.57

52 Week Low

₹ 1.98

Book Value Per Share

₹ 6.69

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Dolphin Medical Services Ltd

Your Vote -

Buy

75.00%

Hold

0.00%

Sell

25.00%

75.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Dolphin Medical Services Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dolphin Medical - Announcement under Regulation 30 (LODR)-Change in Management

    21 Sep 2026, 1:49PM BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters
  • Dolphin Medical - Announcement under Regulation 30 (LODR)-Change in Management Control

    21 Sep 2026, 1:48PM BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters
  • Dolphin Medical - Board Meeting Intimation for To Consider And Approve The Appointment Of Mr. Amarandhar Reddy Kotha (DIN: 07

    20 Sep 2026, 9:52PM Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to cons
  • Dolphin Medical - Board Meeting Outcome for Intimation Of Resignation Of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA And Mr. DWA

    12 Sep 2026, 7:36PM Intimation of Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.
  • Dolphin Medical - Announcement under Regulation 30 (LODR)-Change in Management

    12 Sep 2026, 7:33PM Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA
  • Dolphin Medical - Intimation Of Extension Of AGM

    3 Sep 2026, 10:40AM Intimation of Extension of AGM
  • Dolphin Medical - Post-Offer Advertisement

    28 Aug 2026, 2:41PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms o
  • Dolphin Medical - Results: Unaudited Financial Results For The Quarter Ended June 30, 2026

    14 Aug 2026, 9:20PM Results
  • Dolphin Medical - Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026

    14 Aug 2026, 9:16PM Board meeting outcome
  • Dolphin Medical - Updates on Open Offer

    30 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Annou
  • Dolphin Medical - Recommendations of the Committee of Independent Directors ('IDC')

    29 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (
  • Dolphin Medical - Recommendations of the Committee of Independent Directors ('IDC')

    29 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (
  • Dolphin Medical - Recommendations of the Committee of Independent Directors ('IDC')

    29 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (
  • Dolphin Medical - Recommendations of the Committee of Independent Directors ('IDC')

    29 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (
  • Dolphin Medical - Recommendations of the Committee of Independent Directors ('IDC')

    29 Jul 2026, 5:58PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (
  • Dolphin Medical - Letter of Offer

    27 Jul 2026, 8:12AM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has submitted to BSE a copy of Letter of Offer (\LOF\) to the public shareholders of Dolph
  • Dolphin Medical - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    25 Jul 2026, 7:25PM Ms. Vaishnavi Sharma, Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.
  • Dolphin Medical - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

    25 Jul 2026, 7:21PM Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.
  • Dolphin Medical - Updates on Open Offer (Identified Date)

    16 Jul 2026, 12:45PM Rarever Financial Advisors Pvt Ltd (\Manager to the Offer\) has informed BSE regarding the identified date for the purpose of determining the names of

Key fundamentals

Evaluate the intrinsic value of Dolphin Medical Services Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 10.9477 10.9059 10.8762 10.9325 10.986
Liabilities 10.9477 10.9059 10.8762 10.9325 10.986
Equity 15.0999 15.0999 15.0999 15.0999 15.0999
Gross Profit 0.1242 0.005 -0.0771 -0.0824 -0.1408
Net Profit 0.0419 -0.0338 -0.104 -0.1245 -0.1874
Cash From Operating Activities 0.1358 -0.0597 -0.045 -0.069 -0.0986
NPM(%) 5.58 -4.33 -15.33 -20.38 -36.03
Revenue 0.7501 0.7794 0.6785 0.6112 0.5203
Expenses 0.6259 0.7743 0.7556 0.6936 0.6611
ROE(%) 0.41 -0.33 -1.03 -1.23 -1.85

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dolphin Medical Services Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 788.00 -1.55 20.04 3.78 -26.19 0.63
Lotus Eye Hospital and Institute Ltd 115.00 0.88 1630.00 13.79 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 8.75 -1.02 0.00 28.63 -39.50 0.00
Astec Lifesciences Ltd 722.50 1.11 0.00 14.77 -363.14 0.00

Company Info

The company was originally incorporated as Dolphin Scanning Services Ltd., on 21st September, 1992 and obtained Certificate of commencement of business on 7th Octboer, 1992. The name was subsequently changed to Dolphin Medical Services Ltd. and fresh certificate of incorporation was obtained consequent upon the change of name on 8th November, 1993. The company was promoted by Dr. M.S.S. Koteswara Rao, Dr. G.V. Mohan Prasad, Dr. K. Anil Kumar, Dr. K.J.V. Nageswar and associates. The company is providing services in the Health care business. The company proposes to provide services in various medical fields including diagnostic, ophthalmology, cancer detection and treatment, neurology, urology, gastroenterology etc. 2004 -Dolphin Medical Services ties up with HDFC Standard Life Insurance Co. Ltd 2005 -Dolphin Medical Services Ltd Issues Rights in the Ratio of 3:1

The company was originally incorporated as Dolphin Scanning Services Ltd., on 21st September, 1992 and obtained Certificate of commencement of business on 7th Octboer, 1992. The name was subsequently changed to Dolphin Medical Services Ltd. and fresh certificate of incorporation was obtained consequent upon the change of name on 8th November, 1993. The company was promoted by Dr. M.S.S. Koteswara Rao, Dr. G.V. Mohan Prasad, Dr. K. Anil Kumar, Dr. K.J.V. Nageswar and associates. The company is providing services in the Health care business. The company proposes to provide services in various medical fields including diagnostic, ophthalmology, cancer detection and treatment, neurology, urology, gastroenterology etc. 2004 -Dolphin Medical Services ties up with HDFC Standard Life Insurance Co. Ltd 2005 -Dolphin Medical Services Ltd Issues Rights in the Ratio of 3:1

Parent Organisation

Dolphin Medical Services Ltd.

Founded

21/09/1992

Managing Director

Dr.G V Mohan Prasad

NSE Symbol

FAQ